SEC Form 4 · accession 0001596771-15-000032
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean Whelan
Officer — Chief Financial Officer · Director
Period of report
Mar 31, 2015
Accepted (ET)
Apr 1, 2015 · 3:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common StockF2,F1 | $3.79 | Mar 31, 2015 | D | 357,099 | D | — | Dec 16, 2020 | Common Stock | 357,099 | 0 | D |
Explanation of responses
- F1The options were granted on 12/16/2010 and were fully vested on 12/16/2014.
- F2On March 31, 2015, the options designated in column 5 were repurchased by the Issuer. The purchase price for the option repurchase was based on the $29.00 per common share price of the Issuer's March 25, 2015 public offering, net of the underwriting discount ($1.45) and the per share exercise price of the options.